BGSF filed Q1 2026 results after the close on May 6, with the earnings call scheduled for the morning of May 7 — and the print arrived with a split verdict that captures exactly where the staffing company stands right now.
Adjusted EPS came in at -$0.06, beating the consensus estimate of -$0.12 by $0.06. That's a meaningful beat on the bottom line. Revenue, though, missed: $20.88 million against a $21.0 million estimate. For context, Q4 2025 sales were $22.03 million and the full-year 2025 total was $93.31 million, down from $104.4 million in 2024. The top-line pressure has been grinding in the same direction for over a year.
The lending market tells a story of shorts stepping back ahead of the print. Short interest fell 22% over the week to just 0.49% of the free float — a level so low it barely registers as a short thesis. Cost to borrow is negligible at 0.58%, and borrow availability is loose, with lending pool utilization well below 15% against a 52-week peak near 33%. There was a notable intra-week spike in short positions through late April, which hit a 30-day high around April 28-29 before reversing sharply into May. That pattern looks more like a tactical trade into earnings than a structural bear position. Options activity is minimal — the put/call ratio of 0.04 is far below its 20-day average of 0.057, and the 52-week high of 1.44 shows just how muted options activity currently is. There is no hedging signal here.
Analyst coverage is thin, and the most recent formal data is stale by ORTEX standards — Roth MKM last acted on the stock in March 2025, lowering its target from $12 to $9 while maintaining a Buy rating. The current mean price target of $10.50 implies significant return potential from the $5.43 close, but with coverage so sparse and the last action over a year old, that gap reflects neglect as much as conviction. The RSI-14 reads 34.45, deep into oversold territory, and the stock is down 14% over the past month. Year-to-date, the stock is still up 17%, which suggests the recent slide has unwound most of the early-year recovery.
The institutional register is notable for what it shows about engagement. Poplar Point Capital Management entered as a new holder in Q4 2025, reporting 592,296 shares — roughly 5.3% of the company — a position built from zero. Vanguard and Dimensional added shares modestly in Q1 2026. Driehaus Capital picked up 31,860 shares through February. These are small, quiet additions, but the Q1 2026 data shows more buying than selling among active managers. Insider trade data is stale (last transaction June 2024), so it carries no weight in this week's read.
The Q1 2026 earnings call on the morning of May 7 is the next concrete data point. What the market will want to hear is whether the revenue decline is stabilising — Q4 2025 showed $22 million, Q1 2026 came in at $20.88 million — and whether any forward commentary on staffing demand supports the EPS beat or flags further top-line headwinds. The short-score reading of 32.98 (out of 100) sits in the lower half of the universe, consistent with the very light short positioning, but the earnings reaction and call commentary are what will define the next directional move for this micro-cap.
See the live data behind this article on ORTEX.
Open BGSF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
